Morais Carlos L, Guedes Liana B, Hicks Jessica, Baras Alexander S, De Marzo Angelo M, Lotan Tamara L
Pathology, Johns Hopkins School of Medicine, Baltimore, MD 21231.
Pathology, Johns Hopkins School of Medicine, Baltimore, MD 21231; Urology, Johns Hopkins School of Medicine, Baltimore, MD 21231; Oncology, Johns Hopkins School of Medicine, Baltimore, MD 21231.
Hum Pathol. 2016 Sep;55:117-25. doi: 10.1016/j.humpath.2016.04.017. Epub 2016 May 14.
High-grade prostatic intraepithelial neoplasia (HGPIN) is widely believed to represent a precursor to invasive prostatic adenocarcinoma. However, recent molecular studies have suggested that retrograde spread of invasive adenocarcinoma into pre-existing prostatic ducts can morphologically mimic HGPIN. Thus, previous molecular studies characterizing morphologically identified HGPIN occurring in radical prostatectomies or needle biopsies with concurrent invasive carcinoma may be partially confounded by intraductal spread of invasive tumor. To assess ERG and PTEN status in HGPIN foci likely to represent true precursor lesions in the prostate, we studied isolated HGPIN occurring without associated invasive adenocarcinoma in cystoprostatectomies performed at Johns Hopkins between 2009 and 2014. Of 344 cystoprostatectomies, 33% (115/344) contained invasive prostatic adenocarcinoma in the partially submitted prostate (10 blocks/case on average) and were excluded from the study. Of the remaining cases without sampled cancer, 32% (73/229) showed 133 separate foci of HGPIN and were immunostained for ERG and PTEN using genetically validated protocols. Of foci of HGPIN with evaluable staining, 7% (8/107) were positive for ERG. PTEN loss was not seen in any HGPIN lesion (0/88). Because these isolated HGPIN foci at cystoprostatectomy are unlikely to represent retrograde spread of invasive tumor, our study suggests that ERG rearrangement, but not PTEN loss, is present in a minority of potential neoplastic precursor lesions in the prostate.
高级别前列腺上皮内瘤变(HGPIN)被广泛认为是浸润性前列腺腺癌的前驱病变。然而,最近的分子研究表明,浸润性腺癌逆行扩散至先前存在的前列腺导管可在形态上模拟HGPIN。因此,以往对根治性前列腺切除术或穿刺活检中形态学鉴定的HGPIN伴发浸润性癌进行分子特征分析的研究,可能部分受到浸润性肿瘤导管内扩散的干扰。为了评估HGPIN病灶中可能代表前列腺真正前驱病变的ERG和PTEN状态,我们研究了2009年至2014年在约翰·霍普金斯医院进行的膀胱前列腺切除术中未伴有浸润性腺癌的孤立性HGPIN。在344例膀胱前列腺切除术中,33%(115/344)在部分送检的前列腺(平均每例10个组织块)中含有浸润性前列腺腺癌,被排除在研究之外。在其余未检出癌症的病例中,32%(73/229)显示有133个独立的HGPIN病灶,并使用经过基因验证的方案对ERG和PTEN进行免疫染色。在可评估染色的HGPIN病灶中,7%(8/107)ERG呈阳性。在任何HGPIN病变中均未发现PTEN缺失(0/88)。由于膀胱前列腺切除术中这些孤立的HGPIN病灶不太可能代表浸润性肿瘤的逆行扩散,我们的研究表明,ERG重排而非PTEN缺失存在于少数前列腺潜在肿瘤前驱病变中。